What is the ImmunoPrecise Antibodies Ltd. stock price forecast?

ImmunoPrecise Antibodies Ltd. is currently trading at $1.47. View real-time AI analysis on Alpha Lenz.

What is ImmunoPrecise Antibodies Ltd. insider trading activity?

View the latest insider trading data for ImmunoPrecise Antibodies Ltd. on Alpha Lenz.

What is ImmunoPrecise Antibodies Ltd.'s P/E ratio?

ImmunoPrecise Antibodies Ltd.'s P/E ratio is -1.6.

ImmunoPrecise Antibodies Ltd.

NASDAQ · HYFT

$1.47-0.09(-5.77%)Pre-market

Ask about ImmunoPrecise Antibodies Ltd.'s future dividend policy...

Alpha Chat Insight

“ImmunoPrecise Antibodies Ltd. trades at a P/E of -1.6 (undervalued) with modest ROE of -128.0%.”

Ask for details →

Company Overview

MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

CEODr. Jennifer Lynne Bath Ph.D.

Websitehttps://www.mindwalkai.com

SectorHealthcare

IndustryBiotechnology

Employees81

Company Statistics

FY 2025

Profile

$49.08MMarket Cap

$24.52MRevenue

0.00Shares Out

81Employees

Margins

55.25%Gross

-28.86%EBITDA

-49.74%Operating

-139.75%Pre-Tax

-123.30%Net

Valuation

-1.62P/E

2.08P/B

2.00EV/Sales

-7.32EV/EBITDA

-6.81P/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-68.03%ROA

-127.97%ROE

-76.45%ROIC

Financial Health

$10.66MCash & Cash Equivalents

$10.15MNet Debt

88.10%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“ImmunoPrecise Antibodies Ltd. trades at a P/E of -1.6 (undervalued) with modest ROE of -128.0%.”

Ask for details →

Frequently Asked Questions

ImmunoPrecise Antibodies Ltd. (ticker: HYFT) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 81 employees. Market cap is $49M.

The current price is $1.47 with a P/E ratio of -1.62x and P/B of 2.08x.

ROE is -127.97% and operating margin is -49.74%. Annual revenue is $25M.